Gauge, depth, dental implant Australia - English - Department of Health (Therapeutic Goods Administration)

gauge, depth, dental implant

shagan investments and developments pty ltd -

Oral care kit, reusable Australia - English - Department of Health (Therapeutic Goods Administration)

oral care kit, reusable

shagan investments and developments pty ltd -

Dental material, Australia - English - Department of Health (Therapeutic Goods Administration)

dental material,

shagan investments and developments pty ltd -

Cryolipolysis skin contouring system Australia - English - Department of Health (Therapeutic Goods Administration)

cryolipolysis skin contouring system

tina tran -

ALPHAGAN P 1.5 brimonidine tartrate 0.15% eye drop bottle Australia - English - Department of Health (Therapeutic Goods Administration)

alphagan p 1.5 brimonidine tartrate 0.15% eye drop bottle

abbvie pty ltd - brimonidine tartrate, quantity: 1.5 mg/ml - eye drops, solution - excipient ingredients: magnesium chloride hexahydrate; boric acid; sodium chlorite; sodium chloride; carmellose sodium; borax; sodium hydroxide; purified water; hydrochloric acid; potassium chloride; calcium chloride dihydrate - alphagan p 1.5 eye drops are effective in lowering elevated intraocular pressure in patients with chronic open angle glaucoma or ocular hypertension. alphagan p 1.5 eye drops can be used in the treatment of glaucoma as either monotherapy or in combination with topical beta blockers.

ALPHAGAN Brimonidone tartrate 2mg/mL eye drop bottle Australia - English - Department of Health (Therapeutic Goods Administration)

alphagan brimonidone tartrate 2mg/ml eye drop bottle

abbvie pty ltd - brimonidine tartrate, quantity: 2 mg/ml - eye drops, solution - excipient ingredients: sodium hydroxide; purified water; sodium chloride; polyvinyl alcohol; citric acid; benzalkonium chloride; hydrochloric acid; sodium citrate dihydrate - indications: alphagan eye drops are effective as monotherapy for lowering intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension in whom (beta symbol)-blockers are not tolerated or are contraindicated. indications as at 7 december 1999: alphagan eye drops are effective in lowering elevated intraocular pressure in patients with chronic open angle glaucoma or ocular hypertension. alphagan eye drops can be used in the treatment of glaucoma either as monotherapy or in combination with topical beta-blockers.

Alphagan P Australia - English - Department of Health (Therapeutic Goods Administration)

alphagan p

allergan australia pty ltd - brimonidine tartrate -

Alphagan Australia - English - Department of Health (Therapeutic Goods Administration)

alphagan

allergan australia pty ltd - brimonidine tartrate -

ALPHAGAN PURITE SOLUTION South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

alphagan purite solution

abbvie (pty) ltd - solution - see ingredients - each 1,0 ml solution contains brimonidine tartrate 1,5 mg

Alphagan New Zealand - English - Medsafe (Medicines Safety Authority)

alphagan

abbvie limited - brimonidine tartrate 2 mg/ml;   - eye drops, solution - 0.2 % - active: brimonidine tartrate 2 mg/ml   excipient: benzalkonium chloride citric acid monohydrate hydrochloric acid polyvinyl alcohol purified water sodium chloride sodium citrate dihydrate sodium hydroxide - alphagan® eye drops are effective for lowering intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension.